Related Experiment Video
Updated: Jul 19, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
Lu Tang1,2,3, Zhongpei Huang1,2,3, Heng Mei4,5,6,7
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022, Wuhan, China.
Immunotherapies offer new hope for blood cancer patients, showing potential for long-term remission. This review covers advances, clinical trials, and future directions for these revolutionary treatments.
Area of Science:
- Hematologic malignancies
- Immunotherapy research
- Cancer immunology
Background:
- Hematologic malignancies originate from immune cells, offering unique insights into immune responses and escape.
- Immunotherapy has revolutionized blood cancer treatment, leading to paradigm shifts and clinical success.
Purpose of the Study:
- To provide a comprehensive review of immunotherapy applications and clinical considerations in hematologic malignancies.
- To outline recent advances, mechanisms, clinical trials, and future directions in the field.
Main Methods:
- Review of current literature on various immunotherapy categories for blood cancers.
- Analysis of clinical trial outcomes, adverse effects, and toxicity management.
Main Results:
- Multiple immunotherapies (stem cell transplant, checkpoint inhibitors, etc.) show potential for long-term remission in refractory/relapsed patients.
- These approaches have demonstrated significant clinical success, altering cancer treatment paradigms.
Conclusions:
- Immunotherapy represents a significant advancement in treating hematologic malignancies, with ongoing research addressing existing challenges.
- Further research and clinical evaluation are crucial for optimizing efficacy and managing toxicity.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Microorganisms in Medicine and Therapeutics